These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9161321)

  • 1. Do neuroleptic drugs hasten cognitive decline in dementia? Carriers of apolipoprotein E epsilon 4 allele seem particularly susceptible to their effects.
    Holmes C; Fortenza O; Powell J; Lovestone S
    BMJ; 1997 May; 314(7091):1411; author reply 1412. PubMed ID: 9161321
    [No Abstract]   [Full Text] [Related]  

  • 2. Do neuroleptic drugs hasten cognitive decline in dementia? Authors have not proved their argument.
    Bentham PW; Goh SE; Gregg EM; Madeley P; Patel AR; Taylor AP
    BMJ; 1997 May; 314(7091):1412. PubMed ID: 9161323
    [No Abstract]   [Full Text] [Related]  

  • 3. Do neuroleptic drugs hasten cognitive decline in dementia? Trials must determine which neuroleptics are best in dementia.
    Tobiansky R; Blanchard M
    BMJ; 1997 May; 314(7091):1411; author reply 1412. PubMed ID: 9161322
    [No Abstract]   [Full Text] [Related]  

  • 4. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals.
    Kim KW; Youn JC; Jhoo JH; Lee DY; Lee KU; Lee JH; Woo JI
    Int J Geriatr Psychiatry; 2002 Jul; 17(7):635-40. PubMed ID: 12112161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive change and the APOE epsilon 4 allele.
    Deary IJ; Whiteman MC; Pattie A; Starr JM; Hayward C; Wright AF; Carothers A; Whalley LJ
    Nature; 2002 Aug; 418(6901):932. PubMed ID: 12198535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
    Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H
    Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E, cardiovascular disease and cognitive function in aging women.
    Kang JH; Logroscino G; De Vivo I; Hunter D; Grodstein F
    Neurobiol Aging; 2005 Apr; 26(4):475-84. PubMed ID: 15653176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline.
    Shadlen MF; Larson EB; Wang L; Phelan EA; McCormick WC; Jolley L; Teri L; van Belle G
    Neurobiol Aging; 2005 Jan; 26(1):17-24. PubMed ID: 15585342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterogeneity of the frequency of the apolipoprotein E-epsilon 4 allele in the European population].
    Beránek M; Friedecký B; Palicka V
    Cas Lek Cesk; 1999 Aug; 138(16):500-3. PubMed ID: 10566228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E epsilon 4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica.
    Jordan BD; Kanik AB; Horwich MS; Sweeney D; Relkin NR; Petito CK; Gandy S
    Ann Neurol; 1995 Oct; 38(4):698-9. PubMed ID: 7574475
    [No Abstract]   [Full Text] [Related]  

  • 14. Mortality is associated with apolipoprotein E epsilon4 in nondemented adults with Down syndrome.
    Zigman WB; Jenkins EC; Tycko B; Schupf N; Silverman W
    Neurosci Lett; 2005 Dec; 390(2):93-7. PubMed ID: 16122874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.
    de la Fuente-Fernández R; Núñez MA; López E
    Clin Neuropharmacol; 1999; 22(4):226-30. PubMed ID: 10442253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
    Klages J; Fisk JD
    Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
    van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
    Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.